Cardiovascular manifestations of HIV infection.
Ho
Jennifer E
JE
Cardiology Division, San Francisco General Hospital, University of California, San Francisco, San Francisco, California 94110, USA.
Hsue
Priscilla Y
PY
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001916:Brachial Artery / Q000502:physiology; D002114:Calcinosis / Q000821:virology; D002340:Carotid Artery Diseases / Q000473:pathology / Q000821:virology; D002561:Cerebrovascular Disorders / Q000821:virology; D003324:Coronary Artery Disease / Q000473:pathology / Q000821:virology; D003327:Coronary Disease / Q000097:blood / Q000473:pathology / Q000821:virology*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000821:virology; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D050356:Lipid Metabolism / Q000502:physiology; D024821:Metabolic Syndrome / Q000821:virology; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology; D014664:Vasodilation / Q000502:physiology
D000960:Hypolipidemic Agents